Article

Prophylactic domain-based vaccine against SARS-CoV-2, causative agent of COVID-19 pandemic

2020-06-02

Abstract excerpt

<title>Abstract</title> <p>Coronavirus disease 2019 (COVID-19) is undoubtedly the most challenging pandemic in the current century with more than 253,381 deaths worldwide since its emergence in late 2019 (updated May 6<sup>th</sup>, 2020). COVID-19 is caused by a novel emerged coronavirus named as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Today, the world needs crucially to develop a prophylac...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2240a6f8-b964-5219-b6c0-3ca0fcbe3164
DOI: 10.21203/rs.3.rs-32539/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Prophylactic domain-based vaccine against SARS-CoV-2, causative agent of COVID-19 pandemicDOI 10.21203/rs.3.rs-32539/v1Read

Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studiesSemantic proximity Read

Scrutinizing the SARS-CoV-2 protein information for the designing an effective vaccine encompassing both the T-cell and B-cell epitopesSemantic proximity Read

Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2 etiologic agent of global pandemic COVID-19: an in silico approachSemantic proximity Read

Designing Multi-Epitope Vaccines to Combat Emerging Coronavirus Disease 2019 (COVID-19) by Employing Immuno-Informatics ApproachSemantic proximity Read

Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection.Semantic proximity Read

The multi-epitope vaccine prediction to combat Pandemic SARS-CoV-2, an immunoinformatic approachSemantic proximity Read

Designing a novel vaccine against COVID-19 based on spike SARS-Cov-2 notable mutations using immunoinformatics approaches.Semantic proximity Read

COVID-19 Variants and Vaccine Development.Semantic proximity Read

COVID-19 Vaccines: Where Do We Stand at the End of 2023?Semantic proximity Read

COVID-19 Variants and Vaccine DevelopmentSemantic proximity Read

COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic StrategiesSemantic proximity Read

Multiepitope Subunit Vaccine Design against COVID‐19 Based on the Spike Protein of SARS‐CoV‐2: An In Silico AnalysisSemantic proximity Read